GlassScriptPhysician profile
Joel C Bolen
NPI 1063576130
$3,942.67
in general payments reported to CMS, 2019-2025
39 companies · $304 in 2025
The $304 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $846 · 2020: $943 · 2021: $643 · 2022: $498 · 2023: $322 · 2024: $388 · 2025: $304.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,013.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,013.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $946.36 | 2019-2022 | |
| Pfizer INC. | $349.21 | 2019-2022 | |
| Biogen, INC. | $185.01 | 2020-2025 | Leqembi |
| Otsuka America Pharmaceutical, INC. | $159.77 | 2023-2025 | Nuedexta, Rexulti |
| Janssen Pharmaceuticals, INC | $143.08 | 2019-2021 | |
| Abbvie INC. | $125.82 | 2020-2021 | |
| Amgen INC. | $119.47 | 2021-2025 | Evenity, Prolia |
| Novartis Pharmaceuticals Corporation | $119.20 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $118.66 | 2020-2022 | |
| Lilly USA, LLC | $117.92 | 2021-2024 | Amyvid, Kisunla |
| Ucb, INC. | $115.89 | 2020-2024 | Briviact |
| Collegium Pharmaceutical, INC. | $114.19 | 2020-2025 | Xtampza |
| Eisai INC. | $111.84 | 2023-2024 | |
| Mylan Specialty L.P. | $90.11 | 2019-2023 | Yupelri |
| Amneal Pharmaceuticals LLC | $86.18 | 2020-2025 | Crexont, Rytary |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joel Bolen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.